CME Group, the world’s derivatives marketplace, announced on June 30 that it will introduce single stock futures on July 27, 2026, subject to final regulatory ...
With a short percentage of shares outstanding of 1.26%, CME Group Inc. (NASDAQ:CME) is among the 7 Best Crypto Exchange Stocks to Buy Following Bitcoin’s Recovery. On June 11, CME Group Inc.
The world's largest derivatives exchange is taking the CFTC to court over its decision to greenlight perpetual futures in the U.S.
The CFTC recently greenlighted Kalshi’s plan to list perps in the U.S. CME, the dominant derivatives exchange, argued the regulator violated federal law.
New 90% and 50% futures and options contracts will help manage risk across the cattle supply chain, with trading expected to ...
CME Group CEO Terrence Duffy says the exchange will sue the CFTC on Thursday, arguing that bitcoin perpetual futures approved for Kalshi and Coinbase should not be considered futures.
CME Group (CME) plans to launch Bitcoin Volatility futures on June 1, allowing investors to manage their market and portfolio positions by isolating volatility risks from price direction. "With our ...
CME Group, the largest derivatives exchange in the world, has announced plans to launch XRP futures on May 19, pending regulatory approval. This represents a significant addition to its crypto product ...
June 17 (Reuters) - CME Group chief Terry Duffy, who announced his plans to step down from his role next year, told CNBC in an interview that the exchange operator will sue the Commodity Futures ...
CHICAGO, July 22, 2025 /PRNewswire/ -- CME Group and Nasdaq (Nasdaq: NDAQ) today announced a ten-year extension of CME Group's exclusive license to offer futures and options on futures based on the ...
On June 30, 2026, CME Group Inc. (NASDAQ:CME) said it will launch Single Stock futures across more than 50 top U.S. stocks on ...
CME Group, the world’s leading derivatives marketplace, announced it will launch Single Stock futures across more than 50 of the top U.S. stocks on July 27, pending completion of all regulatory review ...